{"pmid":32356578,"title":"Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.","text":["Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.","Dear editor, we have read with interest Dr s Alramthan and Aldaraji contribution to the spectrum of COVID-19 clinical manifestations.(1) Since COVID-19 outbreak begin, new symptoms have been described.(2) Some of them, were not initially highlighted and could be a distinguishing feature of COVID-19 infection, like anosmia or ageusia.(3) Therefore, it is believed that a newly reported one, so-called acute acro-ischemia is another novel clinical manifestation of COVID-19 infection.(4).","Clin Exp Dermatol","Torres-Navarro, I","Abril-Perez, C","Roca-Gines, J","Sanchez-Arraez, J","Botella-Estrada, R","Evole-Buselli, Montserrat","32356578"],"abstract":["Dear editor, we have read with interest Dr s Alramthan and Aldaraji contribution to the spectrum of COVID-19 clinical manifestations.(1) Since COVID-19 outbreak begin, new symptoms have been described.(2) Some of them, were not initially highlighted and could be a distinguishing feature of COVID-19 infection, like anosmia or ageusia.(3) Therefore, it is believed that a newly reported one, so-called acute acro-ischemia is another novel clinical manifestation of COVID-19 infection.(4)."],"journal":"Clin Exp Dermatol","authors":["Torres-Navarro, I","Abril-Perez, C","Roca-Gines, J","Sanchez-Arraez, J","Botella-Estrada, R","Evole-Buselli, Montserrat"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32356578","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/ced.14255","locations":["Alramthan"],"weight":0,"_version_":1666138495168544768,"score":9.490897,"similar":[{"pmid":32302422,"title":"A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East.","text":["A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East.","Clinical characteristics of COVID-19 disease were identified in a cohort study involving 1099 patients from China. COVID-19 most commonly present with fever, cough, fatigue, and congestion. Two out of 1099 patients were reported to have skin rash, but time of onset and clinical description of rash were missing (Reference B). Another study focused primarily on cutaneous manifestations associated with COVID-19 evaluated 88 patients from Italy. 18 out of the 88 patients developed cutaneous manifestations, but only 8 patients developed skin lesions at onset of disease.","Clin Exp Dermatol","Alramthan, A","Aldaraji, W","32302422"],"abstract":["Clinical characteristics of COVID-19 disease were identified in a cohort study involving 1099 patients from China. COVID-19 most commonly present with fever, cough, fatigue, and congestion. Two out of 1099 patients were reported to have skin rash, but time of onset and clinical description of rash were missing (Reference B). Another study focused primarily on cutaneous manifestations associated with COVID-19 evaluated 88 patients from Italy. 18 out of the 88 patients developed cutaneous manifestations, but only 8 patients developed skin lesions at onset of disease."],"journal":"Clin Exp Dermatol","authors":["Alramthan, A","Aldaraji, W"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302422","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ced.14243","locations":["China","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494871797760,"score":143.44975},{"pmid":32490640,"title":"Letter to the Editor: Radiological approaches to COVID-19 pneumonia.","text":["Letter to the Editor: Radiological approaches to COVID-19 pneumonia.","Dear editor, We read with great interest the article titled ?Radiological approaches to COVID-19 pneumonia? by Akcay S. et al. in the latest issue of Turk J Med Sci [1]. The authors provided a review of the radiological findings of novel coronavirus disease (COVID-19) pneumonia. We would like to highlight some missing radiological findings in this article, and we want to contribute to some critical radiological findings.","Turk J Med Sci","Ufuk, Furkan","Savas, Recep","Hazirolan, Tuncay","32490640"],"abstract":["Dear editor, We read with great interest the article titled ?Radiological approaches to COVID-19 pneumonia? by Akcay S. et al. in the latest issue of Turk J Med Sci [1]. The authors provided a review of the radiological findings of novel coronavirus disease (COVID-19) pneumonia. We would like to highlight some missing radiological findings in this article, and we want to contribute to some critical radiological findings."],"journal":"Turk J Med Sci","authors":["Ufuk, Furkan","Savas, Recep","Hazirolan, Tuncay"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32490640","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3906/sag-2004-332","keywords":["covid-19","chest computed tomography","diagnosis","pneumonia","radiation"],"topics":["Diagnosis"],"weight":1,"_version_":1668892169416474624,"score":89.88105},{"pmid":32329915,"title":"Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.","text":["Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.","The coronavirus disease 2019 (COVID-19) affects principally the respiratory tract but recent studies described that COVID-19 could present a broader clinical spectrum from the absence of any symptoms to heart (1) , digestive (2) or Ear-Nose-Throat (including anosmia and ageusia) (3) manifestations. Here we report two cases of peculiar skin manifestation.","J Eur Acad Dermatol Venereol","van Damme, C","Berlingin, E","Saussez, S","Accaputo, O","32329915"],"abstract":["The coronavirus disease 2019 (COVID-19) affects principally the respiratory tract but recent studies described that COVID-19 could present a broader clinical spectrum from the absence of any symptoms to heart (1) , digestive (2) or Ear-Nose-Throat (including anosmia and ageusia) (3) manifestations. Here we report two cases of peculiar skin manifestation."],"journal":"J Eur Acad Dermatol Venereol","authors":["van Damme, C","Berlingin, E","Saussez, S","Accaputo, O"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329915","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16523","keywords":["covid-19","sars-cov-2","coronavirus","cutaneous manifestation","skin","urticaria"],"topics":["Case Report"],"weight":1,"_version_":1666138494575050752,"score":78.937325},{"pmid":32314436,"title":"Comment on \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S.","text":["Comment on \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S.","Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), patients with COVID-19 mainly present with fever and respiratory symptoms (2). Isolated sudden onset anosmia has also frequently been reported (3). Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations (4), we read with interest an initial study on the topic entitled \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S. (5).","J Eur Acad Dermatol Venereol","Hedou, M","Carsuzaa, F","Chary, E","Hainaut, E","Cazenave-Roblot, F","Masson Regnault, M","32314436"],"abstract":["Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), patients with COVID-19 mainly present with fever and respiratory symptoms (2). Isolated sudden onset anosmia has also frequently been reported (3). Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations (4), we read with interest an initial study on the topic entitled \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S. (5)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Hedou, M","Carsuzaa, F","Chary, E","Hainaut, E","Cazenave-Roblot, F","Masson Regnault, M"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314436","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16519","keywords":["covid-19 infections","cutaneous manifestations","skin"],"locations":["Chinese","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493420568576,"score":77.49071},{"pmid":32447934,"title":"[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].","text":["[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].","Objective: To investigate the clinical and coagulation characteristics in patients with critical Coronavirus disease 2019 (COVID-19) and acro-ischemia. Methods: The retrospective study included 7 critical COVID-19 patients with acro-ischemia in an intensive care unit (ICU) in Wuhan, from Feb 4 to Feb 15, 2020. The clinical and laboratory data before and during the ICU stay were analyzed. Results: The median age of 7 patients was 59 years and 4 of them were men. Three patients were associated with underlying comorbidities. Fever, cough, dyspnea and diarrhea were common clinical symptoms. All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene. D-dimer, fibrinogen and fibrinogen degradation product (FDP) were significantly elevated in most patients. Prothrombin time was prolonged in 4 patients. D-dimer and FDP levels progressively elevated consistent with COVID-2019 exacerbation. Four patients were diagnosed with disseminated intravascular coagulation (DIC) . Low molecular weight heparin (LMWH) was administrated in 6 patients, which reduced D-dimer and FDP rather than improved clinical symptoms. Five patients died finally and the median time from acro-ischemia to death was 12 days. Conclusions: Coagulation parameters should be monitored closely in critical COVID-2019 patients. The timing and protocol of anticoagulation therapy are still under investigation based on more clinical data.","Zhonghua Xue Ye Xue Za Zhi","Zhang, Y","Cao, W","Xiao, M","Li, Y J","Yang, Y","Zhao, J","Zhou, X","Jiang, W","Zhao, Y Q","Zhang, S Y","Li, T S","32447934"],"abstract":["Objective: To investigate the clinical and coagulation characteristics in patients with critical Coronavirus disease 2019 (COVID-19) and acro-ischemia. Methods: The retrospective study included 7 critical COVID-19 patients with acro-ischemia in an intensive care unit (ICU) in Wuhan, from Feb 4 to Feb 15, 2020. The clinical and laboratory data before and during the ICU stay were analyzed. Results: The median age of 7 patients was 59 years and 4 of them were men. Three patients were associated with underlying comorbidities. Fever, cough, dyspnea and diarrhea were common clinical symptoms. All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene. D-dimer, fibrinogen and fibrinogen degradation product (FDP) were significantly elevated in most patients. Prothrombin time was prolonged in 4 patients. D-dimer and FDP levels progressively elevated consistent with COVID-2019 exacerbation. Four patients were diagnosed with disseminated intravascular coagulation (DIC) . Low molecular weight heparin (LMWH) was administrated in 6 patients, which reduced D-dimer and FDP rather than improved clinical symptoms. Five patients died finally and the median time from acro-ischemia to death was 12 days. Conclusions: Coagulation parameters should be monitored closely in critical COVID-2019 patients. The timing and protocol of anticoagulation therapy are still under investigation based on more clinical data."],"journal":"Zhonghua Xue Ye Xue Za Zhi","authors":["Zhang, Y","Cao, W","Xiao, M","Li, Y J","Yang, Y","Zhao, J","Zhou, X","Jiang, W","Zhao, Y Q","Zhang, S Y","Li, T S"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32447934","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3760/cma.j.issn.0253-2727.2020.008","keywords":["anticoagulation therapy","covid-2019","critical","hypercoagulation status"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Heparin, Low-Molecular-Weight"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213980180480,"score":76.807175}]}